Compound nanoemulsion oral liquid for reducing blood fat and preparation method thereof

An emulsion oral liquid and blood lipid-lowering technology, which is applied in the directions of emulsion delivery, pharmaceutical formulations, and non-active ingredients medical preparations, etc., can solve the problems of reducing the effective content, serious fishy smell of deep-sea fish oil, easy to be oxidized, etc. Low-density lipoprotein, improved sensory quality, and anti-bacterial effect

Inactive Publication Date: 2012-04-18
NORTHWEST A & F UNIV
View PDF3 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the fishy smell of deep-sea fish oil is serious, and it is unacceptable to eat directly
EPA contains 5 unsaturat...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound nanoemulsion oral liquid for reducing blood fat and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] Preparation:

[0056] 1) Weigh the surfactant, co-surfactant, oil phase, EPA deep-sea fish oil, carboxymethyl chitosan, taurine, almond oil, perilla seed oil, natural vitamin E and deionized water according to the proportion of the formula. ;

[0057] 2) Fully stir and mix the surfactant and co-surfactant;

[0058] 3) Add the oil phase, EPA deep-sea fish oil, almond oil, perilla seed oil, natural vitamin E in the proportion of the formula, and mix well;

[0059] 4) adding carboxymethyl chitosan and taurine in the required ratio of the formula to deionized water to make the water phase;

[0060] 5) Slowly add the aqueous phase prepared in step 4) to the solution prepared in step 3) at 20°C, and stir well until a yellow or colorless transparent nanoemulsion that is clear, transparent, low in viscosity and fluid is formed .

[0061] Consists of EPA deep sea fish oil 0.20g, carboxymethyl chitosan 0.15g, taurine 0.10g, almond oil 0.01g, perilla seed oil 0.03g, natural vi...

Embodiment 2

[0063] Consists of EPA deep sea fish oil 0.45g, carboxymethyl chitosan 0.20g, taurine 0.10g, almond oil 0.10g, perilla seed oil 0.10g, natural vitamin E 0.05g, EL-40 4.00g, 1,2- Composed of propylene glycol 0.30g, ethyl acetate 0.15g, deionized water 4.55g.

Embodiment 3

[0065] Composed of EPA deep sea fish oil 1.00g, carboxymethyl chitosan 0.01g, taurine 0.30g, almond oil 0.01g, perilla seed oil 0.01g, natural vitamin E 0.10g, RH-40 3.25g, EL-40 2.62g,

[0066] Composition of glycerol 0.10g, wheat germ oil 0.10g, deionized water 2.50g.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses compound nanoemulsion oral liquid for reducing the blood fat. The particle size of the oral liquid is 1nm-100nm. The compound nanoemulsion oral liquid comprises the following components in percentage by weight: 2%-10% of EPA deep-sea fish oil, 0.1%-4% of carboxymethyl chitosan, 1%-3% of taurine, 0.1%-3% of apricot kernel oil, 0.1%-3% of perilla oil, 0.1%-1% of natural vitamin E, 30%-60% of surfactant, 1%-10% of cosurfactant, 1-6% of oil phase and the balance of deionized water, and the sum of the mass percents of all the components is 100%. The compound nanoemulsion oral liquid can reduce the total cholesterol of the blood, the low-density lipoprotein, the triglyceride and the absorption of lipid simultaneously, has an obvious effect for reducing the blood fat and plays a positive role in preventing the cardiovascular diseases such as cerebral thrombosis, cerebral hemorrhage and high blood pressure and the like.

Description

technical field [0001] The invention relates to a compound preparation for effectively lowering blood fat, which is rich in active ingredients such as EPA, carboxymethyl chitosan and perilla seed oil, and is prepared into a clear, transparent and stable nano-scale microemulsion oral liquid. The invention belongs to the field of health medicine preparation. [0002] Background technique [0003] With the improvement of people's quality of life, opportunities for high-protein and high-fat diets have increased, and the amount of exercise has decreased. The number of patients with hyperlipidemia in my country has reached 160 million. Modern medical certification: Hyperlipidemia is a systemic lipid metabolism abnormality caused by high serum cholesterol (TC), triglyceride (TG) and low-density lipoprotein (LDL) or low serum high-density lipoprotein (HDL) . The incidence of fatty liver in severely obese people caused by hyperlipidemia is as high as 61-94%. The death toll from c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/736A61K47/44A61K47/26A61K9/107A61P3/06A61K31/355A61K31/185A61K31/557
Inventor 欧阳五庆周莹欧阳伸雨
Owner NORTHWEST A & F UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap